Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Pranlukast and mirabegron may work as new diabetes drugs.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

A new combination of tadalafil and finasteride improves drug performance and stability.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Using tamsulosin with finasteride is the most effective and reduces surgery risk for BPH.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Four-amino acid part makes enzyme sensitive to finasteride.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Finasteride, a drug used for anti-hyperplasia, can be effectively delivered in the form of matrix tablets.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

DPP4 is important for scarring and skin regeneration, and managing its activity could improve skin healing treatments.

5α-Reductase inhibitors can negatively impact sexual function.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

New compounds were made that are promising for prostate cancer therapy.